The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - NeoImmuneTech
Stock and Other Ownership Interests - AstraZeneca; NeoImmuneTech
A phase I/II study to evaluate the safety and efficacy of a novel long-acting interleukin-7, NT-I7, for patients with newly diagnosed high-grade gliomas after chemoradiotherapy: The interim result of the phase I data.
 
Jian Li Campian
Consulting or Advisory Role - Alexion Pharmaceuticals; Arbor Pharmaceuticals; Dova Pharmaceuticals; Incyte; Inovio Pharmaceuticals
Speakers' Bureau - Abbvie (I)
Research Funding - NeoImmuneTech
Travel, Accommodations, Expenses - NantWorks
 
Jingqin Luo
No Relationships to Disclose
 
Chai Avvaru
No Relationships to Disclose
 
Ruth Katumba
No Relationships to Disclose
 
Albert H Kim
No Relationships to Disclose
 
Gavin P. Dunn
Leadership - ZIOPHARM Oncology
Patents, Royalties, Other Intellectual Property - Immunovalent Therapeutics
 
Christopher Abraham
No Relationships to Disclose
 
Puspanjali Bhatta
No Relationships to Disclose
 
Se Hwan Yang
Employment - NeoImmuneTech
Leadership - NeoImmuneTech
Stock and Other Ownership Interests - NeoImmuneTech
 
Jean Fan
No Relationships to Disclose
 
Byung Ha Lee
Employment - NeoImmuneTech
 
Sunita Ranjitka
Employment - NeoImmuneTech
Stock and Other Ownership Interests - PRA Health Sciences
 
Ngocdiep T. Le
Employment - NeoImmuneTech
Leadership - NeoImmuneTech
Stock and Other Ownership Interests - NeoImmuneTech
Patents, Royalties, Other Intellectual Property - Novartis
Travel, Accommodations, Expenses - NeoImmuneTech
 
George Ansstas
Consulting or Advisory Role - Novartis
Research Funding - Novocure
 
Tanner Michael Johanns
Consulting or Advisory Role - Geneos; Novocure
 
Milan G Chheda
Research Funding - NeoImmuneTech; NeoImmuneTech (Inst); Orbus Pharma; Orbus Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Zika virus patent
Other Relationship - NeoImmuneTech
 
Jiayi Huang
Research Funding - Cantex Pharmaceuticals; Pfizer/EMD Serono